USANA Health Sciences, Inc.
USNA Consumer Defensive Packaged Foods
USANA Health Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $925.3 million, up 8.28% from fiscal 2024. In the quarter to June 2026, revenue fell 5.33%, EPS fell 323.1% and free cash flow grew 180.6%, each against the same quarter a year earlier.
Follow USNA
USANA Health Sciences, Inc. (USNA) EV/Sales
As of 16 October 2026, USANA Health Sciences, Inc. (USNA) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.1× (August 2026) to 2.7× (July 2018); the current reading is higher than 2% of that period. That is below the Packaged Foods industry median of 0.9× and below the Consumer Defensive sector median of 1.0×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.3× | (56.01%) |
| FY2024 | 0.7× | (21.63%) |
| FY2023 | 0.9× | 2.86% |
| FY2022 | 0.8× | (47.37%) |
| FY2021 | 1.6× | 28.75% |
| FY2020 | 1.2× | (19.55%) |
| FY2019 | 1.5× | (31.28%) |
| FY2018 | 2.2× | 40.68% |
| FY2017 | 1.6× | 13.24% |
| FY2016 | 1.4× | (14.16%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.3× | 31.82% |
| Mar 2026 | 0.2× | (17.31%) |
| Dec 2025 | 0.3× | (36.94%) |
| Sep 2025 | 0.5× | (12.80%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ENHA Enhanced Group Inc. compare | n/m |
| USNA USANA Health Sciences, Inc. | 0.2× |
| NATR Nature's Sunshine Products, Inc. compare | 0.3× |
| BRCC BRC Inc. compare | 0.3× |
| OTLY Oatly Group AB Sponsored ADR compare | 0.9× |
| BGS B&G Foods, Inc. compare | 1.2× |
| BYND Beyond Meat, Inc. compare | 1.3× |
| LWAY Lifeway Foods, Inc. compare | 1.5× |
| PRE Prenetics Global Limited compare | 1.7× |
| Packaged Foods industry median | 0.9× |
| Consumer Defensive sector median | 1.0× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)